diffuse large B-cell lymphoma
Novel Agents Expand Rx for Refractory Lymphoma
Boston—Treatment options for patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) have ...
JUNE 23, 2022
Rituxan Hycela Approved for FL, DLBCL, CLL
Rituximab and hyaluronidase human (Rituxan Hycela, Genentech) was approved for subcutaneous injection for the ...
JUNE 23, 2017
Load more